Chronic asymptomatic pyuria precedes overt urinary tract infection and deterioration of renal function in autosomal dominant polycystic kidney disease

被引:28
|
作者
Hwang, Jin Ho [1 ]
Park, Hayne Cho [1 ,2 ]
Jeong, Jong Cheol [1 ]
Baek, Seon Ha [1 ]
Han, Mi Yeun [1 ]
Bang, Kitae [3 ]
Cho, Jeong Yeon [4 ]
Yu, Suk Hee [5 ]
Yang, Jaeseok [6 ]
Oh, Kook-Hwan [1 ]
Hwang, Young-Hwan [2 ,7 ]
Ahn, Curie [1 ,2 ,6 ]
机构
[1] Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak No, Seoul 110744, South Korea
[2] Seoul Natl Univ Hosp, Res Ctr Rare Dis, Seoul 110744, South Korea
[3] Daejeon Eulji Univ Hosp, Dept Internal Med, Taejon, South Korea
[4] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea
[5] Chung Ang Univ Hosp, Dept Internal Med, Seoul, South Korea
[6] Seoul Natl Univ Hosp, Transplantat Ctr, Seoul 110744, South Korea
[7] Eulji Gen Hosp, Dept Internal Med, Seoul, South Korea
来源
BMC NEPHROLOGY | 2013年 / 14卷
关键词
Polycystic kidney disease; Chronic renal failure; Glomerular filtration rate; Pyuria; Urinary tract infection; CYST FORMATION; PROGRESSION; ADPKD; PKD1; MICE; INACTIVATION; CYSTOGENESIS; PATHOGENESIS; PREVALENCE; DIAGNOSIS;
D O I
10.1186/1471-2369-14-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Urinary tract infection (UTI) occurs in 30%-50% of individuals with autosomal dominant polycystic kidney disease (ADPKD). However, the clinical relevance of asymptomatic pyuria in ADPKD patients remains unknown. Methods: We retrospectively reviewed medical records of 256 ADPKD patients who registered to the ADPKD clinic at Seoul National University Hospital from Aug 1999 to Aug 2010. We defined the asymptomatic pyuria as more than 5-9 white blood cells in high-power field with no related symptoms or signs of overt UTI. Patients were categorized into 2 groups depending on its duration and frequency: Group A included non-pyuria and transient pyuria patients; Group B included recurrent and persistent pyuria patients. The association between asymptomatic pyuria and both the development of overt UTI and the deterioration of renal function were examined. Results: With a mean follow-up duration of 65.3 months, 176 (68.8%) out of 256 patients experienced 681 episodes of asymptomatic pyuria and 50 episodes of UTI. The annual incidence of asymptomatic pyuria was 0.492 episodes/patient/year. The patients in group B showed female predominance (58.5% vs. 42.0%, P=0.01) and experienced an upper UTI more frequently (hazard ratio: 4.612, 95% confidence interval: 1.735-12.258; P=0.002, adjusted for gender and hypertension). The annual change in estimated glomerular filtration rate (Delta eGFR) was significantly larger in magnitude in group B than in group A (-2.7 +/- 4.56 vs. -1.17 +/- 5.8, respectively; P=0.01). Age and Group B found to be the independent variables for Delta eGFR and developing end-stage renal disease (16.0% vs. 4.3%, respectively; P=0.001). Conclusions: Chronic asymptomatic pyuria may increase the risk of developing overt UTI and may contribute to declining renal function in ADPKD.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Chronic asymptomatic pyuria precedes overt urinary tract infection and deterioration of renal function in autosomal dominant polycystic kidney disease
    Jin Ho Hwang
    Hayne Cho Park
    Jong Cheol Jeong
    Seon ha Baek
    Mi Yeun Han
    Kitae Bang
    Jeong Yeon Cho
    Suk Hee Yu
    Jaeseok Yang
    Kook-Hwan Oh
    Young-Hwan Hwang
    Curie Ahn
    BMC Nephrology, 14
  • [2] The detrimental effect of urinary tract infection on renal function in the patients with autosomal dominant polycystic kidney disease
    Ye, M
    Lu, F
    Zhu, YJ
    JOURNAL OF UROLOGY, 2004, 171 (04): : 23 - 23
  • [3] Asymptomatic Pyuria as a Prognostic Biomarker in Autosomal Dominant Polycystic Kidney Disease
    Jones, Brian E.
    Mkhaimer, Yaman G.
    Rangel, Laureano J.
    Chedid, Maroun
    Schulte, Phillip J.
    Mohamed, Alaa K.
    Neal, Reem M.
    Zubidat, Dalia
    Randhawa, Amarjyot K.
    Hanna, Christian
    Gregory, Adriana, V
    Kline, Timothy L.
    Zoghby, Ziad M.
    Senum, Sarah R.
    Harris, Peter C.
    Torres, Vicente E.
    Chebib, Fouad T.
    KIDNEY360, 2022, 3 (03): : 465 - 476
  • [4] Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease
    Miyeun Han
    Hayne Cho Park
    Hyunsuk Kim
    Hyung Ah Jo
    Hyuk Huh
    Joon Young Jang
    Ah-Young Kang
    Seung Hyup Kim
    Hae Il Cheong
    Duk-Hee Kang
    Jaeseok Yang
    Kook-Hwan Oh
    Young-Hwan Hwang
    Curie Ahn
    BMC Nephrology, 15
  • [5] Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease
    Han, Miyeun
    Park, Hayne Cho
    Kim, Hyunsuk
    Jo, Hyung Ah
    Huh, Hyuk
    Jang, Joon Young
    Kang, Ah-Young
    Kim, Seung Hyup
    Cheong, Hae Il
    Kang, Duk-Hee
    Yang, Jaeseok
    Oh, Kook-Hwan
    Hwang, Young-Hwan
    Ahn, Curie
    BMC NEPHROLOGY, 2014, 15
  • [6] SIGNIFICANCE OF URINARY ANGIOTENSINOGEN AS A BIOMARKER FOR RENAL FUNCTION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Park, Hayne C.
    Kim, Hyunsuk
    Koo, Tai Yeon
    Han, Miyeun
    Park, Young Joo
    Oh, Kook-Hwan
    Noh, Jung Woo
    Ha, Il Soo
    Cheong, Hae Il
    Hwang, Young-Hwan
    Ahn, Curie
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 82 - 82
  • [7] Urinary citrate as a marker of renal function in patients with autosomal dominant polycystic kidney disease
    Francisco José Borrego Utiel
    Isidoro Herrera Contreras
    Enoc Merino García
    Maria Victoria Camacho Reina
    Clara Moriana Domínguez
    Esther Ocaña Pérez
    International Urology and Nephrology, 2022, 54 : 873 - 881
  • [8] Urinary tract infections, VUR, and autosomal dominant polycystic kidney disease
    Oren Koslowe
    Rachel Frank
    Bernard Gauthier
    Marcela Vergara
    Howard Trachtman
    Pediatric Nephrology, 2003, 18 : 823 - 825
  • [9] URINARY CITRATE AS A MARKER OF RENAL FUNCTION IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Borrego-Utiel, Francisco-Jose
    Herrera, Isidoro
    Merino Garcia, Enoc
    Moriana Dominguez, Clara
    Camacho Reina, Victoria
    Ocana Perez, Esther
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 333 - 333
  • [10] Urinary citrate as a marker of renal function in patients with autosomal dominant polycystic kidney disease
    Borrego Utiel, Francisco Jose
    Herrera Contreras, Isidoro
    Merino Garcia, Enoc
    Camacho Reina, Maria Victoria
    Moriana Dominguez, Clara
    Ocana Perez, Esther
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (04) : 873 - 881